Best Medication for Unexplained Chronic Cough
Gabapentin is the recommended medication for unexplained chronic cough after a negative workup, started at 300 mg once daily and titrated up to a maximum of 1,800 mg daily in two divided doses as tolerated. 1
Treatment Algorithm
First-Line Pharmacologic Therapy: Gabapentin
The 2016 CHEST guidelines specifically recommend gabapentin as the medication of choice for unexplained chronic cough (Grade 2C recommendation). 1 This recommendation is based on:
- Demonstrated improvement in quality of life in randomized controlled trials
- Acceptable side effect profile when properly monitored
- 90% approval rate from the CHEST Expert Cough Panel (compared to morphine which failed to achieve consensus)
Dosing Protocol:
- Start: 300 mg once daily
- Titrate: Add additional daily doses as tolerated
- Maximum: 1,800 mg daily in two divided doses
- Critical requirement: Discuss risk-benefit profile before starting AND reassess at 6 months before continuing 1
What NOT to Prescribe
The guidelines are equally clear about what should be avoided:
Do NOT prescribe inhaled corticosteroids if the patient has:
- Negative bronchial hyperresponsiveness testing
- Negative eosinophilia markers (sputum eosinophils, exhaled nitric oxide)
- Grade 2B recommendation 1
Do NOT prescribe proton pump inhibitors if the patient has:
- Negative workup for acid gastroesophageal reflux disease
- Grade 2C recommendation 1
Studies showed esomeprazole provided no benefit on cough severity or quality of life in unexplained chronic cough. 1
Non-Pharmacologic First-Line Option
Multimodality speech pathology therapy is also recommended as a therapeutic trial (Grade 2C). 1 This can be used alongside or instead of gabapentin, depending on patient preference and availability.
Important Clinical Caveats
The Morphine Controversy
While low-dose morphine showed efficacy in trials 2, 3, 4, it failed to achieve guideline consensus despite three rounds of voting (only 75% approval vs. 80% required). 1 The panel could not agree on its risk-benefit profile for routine use, even with close monitoring protocols.
Other Agents Studied But Not Recommended
- Erythromycin: Found ineffective in RCTs 1, 5
- Ipratropium bromide: Older study with small sample size, results not replicated 1
- Amitriptyline: Only non-randomized data available 5
Definition Matters
Ensure the cough truly qualifies as "unexplained" - it must:
- Persist >8 weeks
- Remain unexplained after proper investigation
- Persist despite supervised therapeutic trials conducted according to best-practice guidelines 1
Common Pitfall
The most frequent error is labeling a cough as "unexplained" when the workup was incomplete or treatment trials were inadequate. 1 Before prescribing gabapentin, confirm the patient has undergone:
- Objective testing for bronchial hyperresponsiveness and eosinophilic bronchitis, OR
- A therapeutic corticosteroid trial (if indicated)
- Assessment for GERD (if clinically suggested)
Real-World Effectiveness
Recent data suggests that even with guideline-based therapy, 71% of patients report insufficient cough control, and only 14% meet all responder criteria (cough frequency, severity, and quality of life). 6 This underscores that gabapentin, while the best available option, has limitations and patients should be counseled accordingly about realistic expectations.
The evidence base remains limited (Grade 2C reflects low-quality evidence), but gabapentin represents the strongest consensus recommendation when medication is needed for this challenging condition. 1